Concepedia

Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer

Jin Won Kim, Hyun Jin Cho, Miso Kim, Kyung-Hun Lee, Sae‐Won Han, Do‐Youn Oh, Hyuk-Joon Lee, Seock‐Ah Im, Tae-You Kim, Han‐Kwang Yang,

Cancer Chemotherapy and Pharmacology · 2013 · 16 citations · 22 references

DOI

Concepts

References

22

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson et al. · The Lancet · 2010 · 2.3K citations

, , +16

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Andrew Tutt, Mark E. Robson, Judy E. Garber et al. · The Lancet · 2010 · 1.6K citations

, , +13

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

McCarty Ks, Miller Ls, Cox Eb et al. · PubMed · 1985 · 1K citations

, , +17

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

Marcia S. Brose · JNCI Journal of the National Cancer Institute · 2002 · 730 citations · Full text

, , +16

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

Cindy Wilson, Lillian Ramos, Maria R. Villaseñor et al. · Nature Genetics · 1999 · 417 citations

, , +13